Operating Income - Fulcrum Therapeutics Inc (NASDAQ:FULC) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 7.33 USD 2.81%

Updated:

Fulcrum Therapeutics Inc
Operating Income

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Fulcrum Therapeutics Inc
Operating Income Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Operating Income	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Fulcrum Therapeutics Inc NASDAQ:FULC	Operating Income -$110.7m	CAGR 3-Years -16%	CAGR 5-Years -27%	CAGR 10-Years N/A
	Johnson & Johnson NYSE:JNJ	Operating Income $23.4B	CAGR 3-Years 3%	CAGR 5-Years 3%	CAGR 10-Years 3%
	Bristol-Myers Squibb Co NYSE:BMY	Operating Income $10.8B	CAGR 3-Years 22%	CAGR 5-Years 7%	CAGR 10-Years 13%
	Pfizer Inc NYSE:PFE	Operating Income $13.1B	CAGR 3-Years 4%	CAGR 5-Years 8%	CAGR 10-Years -3%
	Merck & Co Inc NYSE:MRK	Operating Income $4.1B	CAGR 3-Years -28%	CAGR 5-Years -19%	CAGR 10-Years -7%
	Eli Lilly and Co NYSE:LLY	Operating Income $10.3B	CAGR 3-Years 15%	CAGR 5-Years 12%	CAGR 10-Years 6%

See Also

Based on the financial report for Dec 31, 2023, Fulcrum Therapeutics Inc's Operating Income amounts to -110.7m USD.

Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for Fulcrum Therapeutics Inc have been -16% over the past three years , -27% over the past five years .

Join more than 133,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.